Joe Rayne

Investor Relations Kontakt bei NUVATION BIO INC.

Health Technology

Commercial Services

Profil

Joe Rayne is currently Head-Investor Relations at Nuvation Bio, Inc. Formerly, Mr. Rayne was Head-Investor Relations at Inotek Pharmaceuticals Corp.
and Vice President at Argot Partners LLC from 2017 to 2021.

Aktive Positionen von Joe Rayne

Unternehmen	Position	Beginn
NUVATION BIO INC.	Investor Relations Kontakt	-

Alle aktiven Positionen von Joe Rayne

Ehemalige bekannte Positionen von Joe Rayne

Unternehmen	Position	Ende
Argot Partners LLC Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy	Corporate Officer/Principal	01.08.2021
Inotek Pharmaceuticals Corp. Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye	Investor Relations Kontakt	-

Sehen Sie sich die Erfahrung von Joe Rayne im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Joe Rayne im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
Inotek Pharmaceuticals Corp. Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye	Health Technology
Argot Partners LLC Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy	Commercial Services
Nuvation Bio, Inc. Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates	Health Technology